Latest available resultsQuarter ended March 31, 202610-Q · April 30, 2026
Filed with the SECCLOROX CO /DE/
CLXConsumer & retail
Results announcedAugust 3, 2026▼ −0.5%
Detailed filing pendingNext reportNovember 2, 2026Analyst forecast 1.138 $/share
Revenue
$1.67B
▲ +0.1% vs prior year% YoY
Net income
$187.00M
▲ +0.5% vs prior year% YoY
EPS
1.54$
▲ +2.7% vs prior year% YoY
Net margin
11.2%
▲ +0.0 percentage points vs prior year pp YoY
Revenue▲ +0.1 %
Margins (% of revenue)GrossOperating N/ANet
Net income▲ +0.5 %
EPS▲ +2.7 %
View financial tableQuarter ended March 31, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.67B | |
| Gross profit | $722.00M | 43.2 % |
| Operating income | — | never filed |
| Net income | $187.00M | 11.2 % |
| R&D | $27.00M | 1.6 % |
| EPS (diluted) | 1.54 $ | |
| Balance sheet | ||
| Assets | $6.44B | |
| Liabilities | $6.34B | |
| Equity | $92.00M | |
| Cash | $1.19B | |
| Capital | ||
| Shares outstanding | 120.92M | as of 2026-04-16 |
| Public float | — | |